Identification of an iron regulation mechanism in patients with beta-thalassemia.
The inhibitor of the iNOS production and the cell motility by the activation of the macrophage
Identification of an iron regulation mechanism in patients with beta-thalassemia.
The inhibitor of the iNOS production and the cell motility by the activation of the macrophage.
Lectures and oral presentations (4)：
Growth differentiation factor 15 is produced at high levels in patients with beta thalassemia and inhibits hepcidin expression in primary hepatocytes
(The 2nd meeting of the International BioIron Society. 2007)
Growth differentiation factor 15 is produced at high levels in patients with beta thalassemia and inhibits hepcidin expression in primary hepatocytes.
(The 2nd meeting of the International BioIron Society. 2007)
Discovery of an erythrokine as an erythroblast-secreted regulator of hepcidin with very high level expression in patients with thalassemia.
(The 48th Annual meeting of the American Society of Hematology. 2006)
Discovery of an erythrokine as an erythroblast-secreted regulator of hepcidin with very high level expression in patients with thalassemia.
(The 48th Annual meeting of the American Society of Hematology. 2006)
Works (1)：
China-Japan-Korea Joint-Bioinformatics Training Course
2005 -
Education (3)：
- 2005 Osaka Prefecture University
- 2001 Osaka Prefecture University
- 2001 Osaka Prefecture University Faculty of Agriculture
Professional career (1)：
獣医学博士 (大阪府立大学)
Awards (2)：
2007 - Best young scientist presentation by Novartis Presidents award at International BioIron Society meeting 2007
2007 - Best young scientist presentation by Novartis Presidents award at International BioIron Society meeting 2007
